☆ 4.7 Article

Disclosing a metabolic signature of cisplatin resistance in MDA-MB-231 triple-negative breast cancer cells by NMR metabolomics

CANCER CELL INTERNATIONAL (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Pharmacology & Pharmacy

Pd(II) and Pt(II) Trinuclear Chelates with Spermidine: Selective Anticancer Activity towards TNBC-Sensitive and -Resistant to Cisplatin

Martin Vojtek et al.

Summary: Triple-negative breast cancer (TNBC) is a highly aggressive form of breast cancer and current drug treatments often face limitations. In this study, Pd(3)Spd(2) was found to be a promising metal-based anticancer agent for TNBC treatment, surpassing its Pt analog in activity. Pd(3)Spd(2) demonstrated similar antiproliferative activity in both sensitive and resistant TNBC cells and showed a promising selectivity index ratio, indicating its potential for further exploration in treating TNBC and its cisplatin-resistant forms.

PHARMACEUTICS (2023)

添加到收藏夹

Article Cell Biology

ERK activation modulates invasiveness and Reactive Oxygen Species (ROS) production in triple negative breast cancer cell lines

Adilene Acosta-Casique et al.

Summary: In this study, the researchers found that TNBC cell lines had increased ERK phosphorylation, which played an important role in cell migration. The increase in ERK phosphorylation upon antioxidant treatment suggested an enhanced invasive potential. Interestingly, MEK inhibitor PD0325901 (PD) treatment reduced ROS levels and decreased mitochondrial fragmentation in TNBC cells, indicating the important role of MEK/ERK in regulating cellular migration, mitochondrial dynamics, and ROS production in this breast cancer subtype.

CELLULAR SIGNALLING (2023)

添加到收藏夹

Article Cell Biology

ERK activation modulates invasiveness and Reactive Oxygen Species (ROS) production in triple negative breast cancer cell lines

Adilene Acosta-Casique et al.

Summary: In this study, we observed increased ERK phosphorylation in TNBC cell lines, indicating a crucial role for ERK in sustaining TNBC cell migration. Additionally, antioxidant treatment paradoxically increased ERK phosphorylation, suggesting a potential link between increased invasion and ROS production. Interestingly, treatment with a MEK inhibitor decreased ROS levels and mitochondrial fragmentation in TNBC cells, highlighting the involvement of MEK/ERK in regulating migration, mitochondrial dynamics, and ROS production in this breast cancer subtype.

CELLULAR SIGNALLING (2023)

添加到收藏夹

Review Oncology

PARP mediated DNA damage response, genomic stability and immune responses

Chunyan Zong et al.

Summary: PARP enzymes, especially PARP1, play important roles in DNA damage response and genome stability maintenance. PARPis can be used as a therapeutic approach for BRCA-deficient tumors, not only through catalytic inhibition and DNA trapping, but also by affecting tumor's immune modulation.

INTERNATIONAL JOURNAL OF CANCER (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

HMDB 5.0: the Human Metabolome Database for 2022

David S. Wishart et al.

Summary: The Human Metabolome Database (HMDB) has been providing comprehensive information about human metabolites since 2007, and has undergone significant improvements and upgrades in its latest update, HMDB 5.0. These improvements include an increase in the number of metabolite entries, enhancements to metabolite descriptions, new visualization tools, and more accurately predicted spectral data sets. These upgrades are aimed at improving the usability and potential applications of the HMDB in various fields, including human metabolomics, exposomics, lipidomics, nutritional science, biochemistry, and clinical chemistry.

NUCLEIC ACIDS RESEARCH (2022)

添加到收藏夹

Review Cell Biology

The two sides of creatine in cancer

Liwen Zhang et al.

Summary: Creatine, a nitrogen-containing organic acid naturally present in mammals, has complex roles in cancer progression, including providing energy, suppressing subcutaneous tumors, and promoting cancer metastasis. Caution should be exercised when considering creatine supplementation in clinical cancer treatment.

TRENDS IN CELL BIOLOGY (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Significance of platinum distribution to predict platinum resistance in ovarian cancer after platinum treatment in neoadjuvant chemotherapy

Kaname Uno et al.

Summary: Platinum distribution in ovarian cancer tissues can predict platinum resistance and prognosis, and guide the selection of appropriate adjuvant chemotherapy.

SCIENTIFIC REPORTS (2022)

添加到收藏夹

Article Oncology

Endocrine Therapy-Resistant Breast Cancer Cells Are More Sensitive to Ceramide Kinase Inhibition and Elevated Ceramide Levels Than Therapy-Sensitive Breast Cancer Cells

Purab Pal et al.

Summary: Endocrine therapy resistance is a critical problem in estrogen receptor-positive breast cancer. This study investigated how alterations in sphingolipids promote cell survival in ET-resistant breast cancer. Through targeted sphingolipidomics analysis, the researchers found that tamoxifen-resistant cells have lower levels of ceramides compared to their sensitive counterparts. They also identified that CERK inhibition induces ceramide-mediated cell death in tamoxifen-resistant cells. These findings suggest that ET-resistant breast cancer cells rely on CERK activity to maintain lower ceramide levels, making CERK a potential therapeutic target.

CANCERS (2022)

添加到收藏夹

Article Oncology

Chemoresistant Cancer Cell Lines Are Characterized by Migratory, Amino Acid Metabolism, Protein Catabolism and IFN1 Signalling Perturbations

Mitchell Acland et al.

Summary: This study aimed to understand the molecular features of chemoresistance in ovarian cancer by comparing the proteome and metabolome of chemosensitive and chemoresistant cell lines. The analysis revealed perturbations in signalling and metabolic pathways in chemoresistant cells and identified a shared dysregulation in cytokine and type 1 interferon signalling. This research contributes to a deeper understanding of chemoresistance and could potentially help in developing better treatment strategies for ovarian cancer.

CANCERS (2022)

添加到收藏夹

Review Oncology

Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance

Taniya Saha et al.

Summary: Breast cancer is the most common malignancy in women worldwide, and drug resistance remains a major challenge. Breast cancer is heterogeneous, with cancer-initiating stem-like cells (bCSCs) playing a role in resistance and invasiveness. Treatment of breast cancer includes surgery, radiotherapy, and systemic therapies. However, the crosstalk between malignant cells and the breast tumor microenvironment, as well as dysregulated miRNAs/ncRNAs patterns in bCSCs, contribute to drug resistance. Targeting bCSCs to reverse drug resistance and increase drug sensitivity is a promising approach in breast cancer research.

FRONTIERS IN ONCOLOGY (2022)

添加到收藏夹

Review Oncology

Regulation of Metabolic Plasticity in Cancer Stem Cells and Implications in Cancer Therapy

Styliani Papadaki et al.

Summary: Cancer cells rely on glycolysis for energy production, while cancer stem cells have the ability to switch between glycolysis and oxidative phosphorylation depending on their energy needs and stimuli from the microenvironment, with this metabolic plasticity being associated with therapy resistance.

CANCERS (2022)

添加到收藏夹

Article Cell Biology

Metabolomic profiling of triple negative breast cancer cells suggests that valproic acid can enhance the anticancer effect of cisplatin

Avital Granit et al.

Summary: Cisplatin-resistance in triple negative breast cancer (TNBC) may be caused by metabolic reprogramming. Supplementation of valproic acid (VPA) alters lipid metabolism, particularly fatty acid oxidation and lipid synthesis, in cisplatin-treated TNBC cells. This finding may lead to the discovery of new therapeutic targets to reduce side effects and counter drug tolerance.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Decreased Levels of GSH Are Associated with Platinum Resistance in High-Grade Serous Ovarian Cancer

Daniela Criscuolo et al.

Summary: The study found that cisplatin treatment may cause metabolic remodeling in ovarian cancer cells, leading to reduced levels of reduced glutathione (GSH) and decreased sensitivity to oxidative stress. Additionally, levels of enzymes involved in GSH synthesis were reduced, while expression of thioredoxin reductase increased. In patients with HGSOC, the expression of the cysteine-glutamate antiporter xCT, which is crucial for GSH synthesis, directly correlated with post-progression survival and was significantly reduced in patients not responding to platinum-based therapy.

ANTIOXIDANTS (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Metallo-Drugs in Cancer Therapy: Past, Present and Future

Roxana Liana Lucaciu et al.

Summary: Conventional cancer treatments like chemotherapy have limited success due to resistance, toxicity and side effects. Finding new therapies remains a challenge.

MOLECULES (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Current landscape of personalized clinical treatments for triple-negative breast cancer

Jun Zhang et al.

Summary: Triple-negative breast cancer is a highly malignant subtype of breast cancer with aggressive behaviors. It is associated with poor clinical outcomes, early recurrence, and a higher likelihood of visceral metastases compared to other types of breast cancer. Personalized or combined therapies based on molecular heterogeneity are showing promising results in treating triple-negative breast cancer.

FRONTIERS IN PHARMACOLOGY (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Development of a novel cell-based, In-Cell Western/ERK assay system for the high-throughput screening of agonists acting on the delta-opioid receptor

Junaid Asghar et al.

Summary: The optimization protocol successfully increased sensitivity, reduced variance, and proved to be cost-effective for high-throughput screening of delta agonists. All DOPr agonists induced concentration-dependent ERK activation, which could be attenuated by pertussis toxin. Selective DOPr antagonists were able to antagonize the ERK activation induced by DOPr agonists.

FRONTIERS IN PHARMACOLOGY (2022)

添加到收藏夹

Article Genetics & Heredity

The Complex Dynamic of Phase I Drug Metabolism in the Early Stages of Doxorubicin Resistance in Breast Cancer Cells

Isabel S. Barata et al.

Summary: The altered activity of drug metabolism enzymes (DMEs) is a hallmark of chemotherapy resistance. This study aimed to investigate the role of Phase I DMEs involved in the first stages of acquisition of DOX-resistance in BC cells. Our results pinpoint the potential role of specific CYPs and oxidoreductases involved in the metabolism of drugs, retinoic and arachidonic acids, in the mechanisms of chemo-resistance to DOX and carcinogenesis of BC.

GENES (2022)

添加到收藏夹

Review Oncology

The mechanism of branched-chain amino acid transferases in different diseases: Research progress and future prospects

Xiazhen Nong et al.

Summary: This article reviews the role and mechanism of BCAT in different diseases, as well as the recent biomedical research progress, providing new research ideas for the treatment, prognosis, and prevention of certain diseases.

FRONTIERS IN ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Triple-negative breast cancer therapeutic resistance: Where is the Achilles' heel?

Xupeng Bai et al.

Summary: TNBC shows higher response rate to systemic therapy but poorer tumor differentiation, with higher tendency to metastasis and recurrence. Relapsed and metastatic TNBCs progress more rapidly, demonstrating strong resistance to chemotherapy and radiotherapy.

CANCER LETTERS (2021)

添加到收藏夹

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Article Cell Biology

BCAT1 decreases the sensitivity of cancer cells to cisplatin by regulating mTOR-mediated autophagy via branched-chain amino acid metabolism

Lifang Luo et al.

Summary: The study revealed that BCAT1 regulates autophagy through the mTOR signaling pathway, decreasing the sensitivity of cancer cells to cisplatin, while branched-chain amino acids or leucine can reverse this process, enhancing the efficacy of cisplatin.

CELL DEATH & DISEASE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

1H -NMR Metabolomics Study of the Effect of Cisplatin and Casiopeina IIgly on MDA-MB-231 Breast Tumor Cells

Karen Resendiz-Acevedo et al.

Summary: The study found that the metallodrugs cisplatin and CasIIgly have different metabolic effects on highly metastatic breast cancer cells. CasIIgly affects carbohydrate and nucleotide metabolism and has a rapid effect, making it a good alternative for treating this type of cancer.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

The Interleukin-6/Signal Transducer and Activator of Transcription-3/Cystathionine g-Lyase Axis Deciphers the Transformation Between the Sensitive and Resistant Phenotypes of Breast Cancer CellsS

Zhaoyi Tan et al.

Summary: This study elucidated the association between drug resistance of cancer cells and redox homeostasis, as well as identified the key role of the IL-6/STAT3/CTH axis in the transformation between sensitive and resistant MCF-7 cells. Modulation of the transsulfuration pathway on CTH or IL-6/STAT3 signaling, along with methionine supplementation, showed potential for reversing the resistance of MCF-7 cells, indicating possible clinical applications.

DRUG METABOLISM AND DISPOSITION (2021)

添加到收藏夹

Article Oncology

Platinum resistance in gynecologic malignancies: Response, disease free and overall survival are predicted by biochemical signature: A metabolomic analysis

Paulo D'Amora et al.

Summary: Metabolic signatures can predict platinum resistance in gynecologic cancer patients, influencing treatment outcomes and survival. Quantitation of metabolites using mass spectrometry, combined with clinical data, can help determine efficacy and prognosis in patients.

GYNECOLOGIC ONCOLOGY (2021)

添加到收藏夹

Review Oncology

Proteins from the DNA Damage Response: Regulation, Dysfunction, and Anticancer Strategies

Caroline Molinaro et al.

Summary: Cells respond to genotoxic stress through complex protein pathways called DNA damage response (DDR), ensuring genomic integrity and activating processes like DNA repair, cell cycle regulation, and programmed cell death. Alterations in DDR network proteins can lead to various diseases, including cancer. Recent technological advancements have allowed for the exploitation of DDR vulnerabilities to improve cancer treatments through DNA damage strategies and combination therapies.

CANCERS (2021)

添加到收藏夹

Article Oncology

Thermodynamic Genome-Scale Metabolic Modeling of Metallodrug Resistance in Colorectal Cancer

Helena A. Herrmann et al.

Summary: The study reveals the metabolic reprogramming in drug-resistant cells sensitive to ruthenium- and platinum-based drugs. The findings suggest that the metabolic reprogramming in resistant cells is primarily limited to a select number of pathways.

CANCERS (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

The Role of Tumour Metabolism in Cisplatin Resistance

Lude Wang et al.

Summary: Cisplatin is a commonly used chemotherapy drug in cancer treatment. However, the drug resistance of tumor cells often leads to treatment failure. Metabolic reprogramming of tumor cells plays a crucial role in tumorigenesis and development.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

添加到收藏夹

Article Oncology

ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma

Victor A. Arrieta et al.

Summary: The study found that ERK1/2 phosphorylation serves as a biomarker for MAPK/ERK pathway activity in glioblastoma patients, predicting response to PD-1 blockade and overall survival. High p-ERK GBMs were associated with a distinct myeloid cell phenotype expressing MHC class II and associated genes.

NATURE CANCER (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Subquinocin, a small molecule inhibitor of CYLD and USP-family deubiquitinating enzymes, promotes NF-κB signaling

Satoshi Yamanaka et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

添加到收藏夹

Article Oncology

Inhibition of Notch1 reverses EMT and chemoresistance to cisplatin via direct downregulation of MCAM in triple-negative breast cancer cells

De Zeng et al.

INTERNATIONAL JOURNAL OF CANCER (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Inhibition of the polyamine synthesis enzyme ornithine decarboxylase sensitizes triple-negative breast cancer cells to cytotoxic chemotherapy

Renee C. Geck et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2020)

添加到收藏夹

Article Biotechnology & Applied Microbiology

SNHG15 Contributes To Cisplatin Resistance In Breast Cancer Through Sponging miR-381

Hailong Mi et al.

ONCOTARGETS AND THERAPY (2020)

添加到收藏夹

Review Medicine, Research & Experimental

ERK/MAPK signalling pathway and tumorigenesis

Yan-Jun Guo et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2020)

添加到收藏夹

Article Genetics & Heredity

Targeted Inhibition of miR-221/222 Promotes Cell Sensitivity to Cisplatin in Triple-Negative Breast Cancer MDA-MB-231 Cells

Shujun Li et al.

FRONTIERS IN GENETICS (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents

Jiabei Zhou et al.

FRONTIERS IN PHARMACOLOGY (2020)

添加到收藏夹

Review Oncology

Metabolic Reprogramming in Triple-Negative Breast Cancer

Sun Xiangyu et al.

FRONTIERS IN ONCOLOGY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Triple Negative Breast Cancer and Breast Epithelial Cells Differentially Reprogram Glucose and Lipid Metabolism upon Treatment with Triterpenic Acids

Angela R. Guerra et al.

BIOMOLECULES (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Inhibition of O-GlcNAc transferase activates tumor-suppressor gene expression in tamoxifen-resistant breast cancer cells

Anna Barkovskaya et al.

SCIENTIFIC REPORTS (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Role of Nucleotide Excision Repair in Cisplatin Resistance

Mingrui Duan et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment

Shang-Hung Chen et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

添加到收藏夹

Article Cell Biology

NAD plus consumption by PARP1 in response to DNA damage triggers metabolic shift critical for damaged cell survival

Michael M. Murata et al.

MOLECULAR BIOLOGY OF THE CELL (2019)

添加到收藏夹

Review Endocrinology & Metabolism

Polyploid giant cancer cells: Unrecognized actuators of tumorigenesis, metastasis, and resistance

Sarah R. Amend et al.

PROSTATE (2019)

添加到收藏夹

Article Oncology

Glutamine Metabolism Drives Growth in Advanced Hormone Receptor Positive Breast Cancer

Diane M. Demas et al.

FRONTIERS IN ONCOLOGY (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Mitochondrial fragmentation, elevated mitochondrial superoxide and respiratory supercomplexes disassembly is connected with the tamoxifen-resistant phenotype of breast cancer cells

Veronika Tomkova et al.

FREE RADICAL BIOLOGY AND MEDICINE (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

The ERK and JNK pathways in the regulation of metabolic reprogramming

Salvatore Papa et al.

ONCOGENE (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Preclinical studies on metal based anticancer drugs as enabled by integrated metallomics and metabolomics

Luis Galvez et al.

METALLOMICS (2019)

添加到收藏夹

Review Oncology

Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy

Tomaz Makovec

RADIOLOGY AND ONCOLOGY (2019)

添加到收藏夹

Article Oncology

ETS1 is associated with cisplatin resistance through IKKα/NF-κB pathway in cell line MDA-MB-231

Yuzhu Zhang et al.

CANCER CELL INTERNATIONAL (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Multi-nucleated cells use ROS to induce breast cancer chemoresistance in vitro and in vivo

Aditya Parekh et al.

ONCOGENE (2018)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Role of the NFκB-signaling pathway in cancer

Longzheng Xia et al.

ONCOTARGETS AND THERAPY (2018)

添加到收藏夹

Review Medicine, General & Internal

DNA repair pathways and cisplatin resistance: an intimate relationship

Clarissa Ribeiro Reily Rocha et al.

CLINICS (2018)

添加到收藏夹

Article Chemistry, Analytical

Impact of chemotherapy on metabolic reprogramming: Characterization of the metabolic profile of breast cancer MDA-MB-231 cells using 1H HR-MAS NMR spectroscopy

Roberta M. Maria et al.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2017)

添加到收藏夹

Review Pathology

Cancer Stem Cells: Basic Concepts and Therapeutic Implications

Dany Nassar et al.

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 11 (2016)

添加到收藏夹

Article Reproductive Biology

A metabolomic approach to identifying platinum resistance in ovarian cancer

Laila M. Poisson et al.

JOURNAL OF OVARIAN RESEARCH (2015)

添加到收藏夹

Article Cell Biology

Acquired cisplatin resistance in human ovarian A2780 cancer cells correlates with shift in taurine homeostasis and ability to volume regulate

Belinda Halling Sorensen et al.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2014)

添加到收藏夹

Article Oncology

Number of glioma polyploid giant cancer cells (PGCCs) associated with vasculogenic mimicry formation and tumor grade in human glioma

Yang Qu et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2013)

添加到收藏夹

Review Oncology

Targeting nuclear factor-kappa B to overcome resistance to chemotherapy

P. Godwin et al.

FRONTIERS IN ONCOLOGY (2013)

添加到收藏夹

Review Nursing

Effect size estimation: Methods and examples

Lut Berben et al.

INTERNATIONAL JOURNAL OF NURSING STUDIES (2012)

添加到收藏夹

Article Cell Biology

NF-κB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration

Claudio Mauro et al.

NATURE CELL BIOLOGY (2011)

添加到收藏夹

Article Biochemical Research Methods

High-throughput tissue extraction protocol for NMR- and MS-based metabolomics

Huifeng Wu et al.

ANALYTICAL BIOCHEMISTRY (2008)

添加到收藏夹

Article Biochemistry & Molecular Biology

Suppression of MEK/ERK signaling pathway enhances cisplatin-induced NF-κB activation by protein phosphatase 4-mediated NF-κB p65 Thr dephosphorylation

PY Yeh et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

添加到收藏夹

Article Biochemistry & Molecular Biology

KEGG: Kyoto Encyclopedia of Genes and Genomes

M Kanehisa et al.

NUCLEIC ACIDS RESEARCH (2000)

添加到收藏夹

Review Pharmacology & Pharmacy

Clinical perspectives on platinum resistance

G Giaccone

DRUGS (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.